Impact of human immunodeficiency virus (HIV) infection on the progression of liver fibrosis in hepatitis C virus infected patients
about
Outcomes and management of viral hepatitis and human immunodeficiency virus co-infection in liver transplantationUnderlying Pathophysiology of HCV Infection in HIV-Positive Drug UsersPegylated IFN-α and ribavirin: emerging data in the treatment of special populations.Meta-analysis: increased mortality associated with hepatitis C in HIV-infected persons is unrelated to HIV disease progression.Prevalence of hepatitis B and C infection in persons living with HIV enrolled in care in Rwanda.Hepatitis C treatment experiences and decision making among patients living with HIV infection.Cocaine Use and Liver Disease are Associated with All-Cause Mortality in the Miami Adult Studies in HIV (MASH) Cohort.The French national prospective cohort of patients co-infected with HIV and HCV (ANRS CO13 HEPAVIH): early findings, 2006-2010.Treatment of hepatitis C virus infection: updated Swedish Consensus recommendations.Hepatitis C virus infection and risk of cancer: a population-based cohort study.X4 Human immunodeficiency virus type 1 gp120 promotes human hepatic stellate cell activation and collagen I expression through interactions with CXCR4Dynamic analysis of Th1/Th2 cytokine concentration during antiretroviral therapy of HIV-1/HCV co-infected patients.Evaluating Liver Fibrosis by Transient Elastometry in Patients With HIV-HCV Coinfection and Monoinfection.Similar progression of fibrosis between HIV/HCV-infected and HCV-infected patients: Analysis of paired liver biopsy samples.Systemic cytokine and interferon responsiveness Patterns in HIV and HCV mono and co-infectionsSustained long-term antiviral maintenance therapy in HCV/HIV-coinfected patients (SLAM-C)HIV-1 tropism and liver fibrosis in HIV-HCV co-infected patientsClinical practice guideline for the management of chronic kidney disease in patients infected with HIV: 2014 update by the HIV Medicine Association of the Infectious Diseases Society of America.HCV viremia is associated with drug use in young HIV-1 and HCV coinfected pregnant and non-pregnant women.High prevalence of liver fibrosis associated with HIV infection: a study in rural Rakai, Uganda.Risk Factors and Seroprevalence of Hepatitis C among Patients Hospitalized at Mulago Hospital, Uganda.CD4 recovery on antiretroviral therapy is associated with decreased progression to liver disease among hepatitis C virus-infected injecting drug usersHepatitis C: What is the nature of the problem?Evidence of distinct populations of hepatitis C virus in the liver and plasma of patients co-infected with HIV and HCV.Generalized Liver- and Blood-Derived CD8+ T-Cell Impairment in Response to Cytokines in Chronic Hepatitis C Virus InfectionHepatitis C virus (HCV) disease progression in people who inject drugs (PWID): A systematic review and meta-analysis.Cost-effectiveness of treatment for hepatitis C in an urban cohort co-infected with HIV.HIV Vpr protein upregulates microRNA-122 expression and stimulates hepatitis C virus replicationHCV/ HIV co-infection: time to re-evaluate the role of HIV in the liver?Hepatic steatosis is associated with fibrosis, nucleoside analogue use, and hepatitis C virus genotype 3 infection in HIV-seropositive patients.Use of the AST to platelet ratio index in HCV/HIV co-infected patients.HIV/HCV co-infection: histopathologic findings, natural history, fibrosis, and impact of antiretroviral treatment: a review article.Systematic review and meta-analysis of the diagnostic accuracy of fibrosis marker panels in patients with HIV/hepatitis C coinfection.The hepatitis C treatment revolution: how to avoid Asia missing outImpact of human immunodeficiency virus infection on the course of hepatitis C virus infection: a meta-analysis.Liver disease in injection drug users with hepatitis C, with and without HIV coinfection.Hepatitis C Virus and HIV Type 1 Co-Infection.Antiretroviral therapy reduces the rate of hepatic decompensation among HIV- and hepatitis C virus-coinfected veterans.Opioids and HIV/HCV infection.The long-term effectiveness of methadone maintenance treatment in prevention of hepatitis C virus among illicit drug users: a modeling study.
P2860
Q26864478-EBBF4DC4-A23A-4540-83CF-B777B509E1E4Q27489073-4CB89AAB-C37A-4E33-9BF2-467941FA130CQ30733177-7AE61406-3A47-4DFD-A426-E10D4FB3465FQ33585762-6E9B2B13-DB83-4AC2-9A79-467DCBD15C10Q33630346-0C6F1722-2037-44A2-B0FE-48640C329BFDQ33636377-CBE51221-E12B-4438-A6E6-B98B2C441A0FQ33712066-827D38CA-8B4D-48EC-AD52-C390E438E380Q33726091-8011540A-1ED8-46DB-AECD-D62683AFFA40Q34087387-3F882FFE-52AB-478C-B4A2-8A0AFDB69963Q34144211-52B93F5B-B51E-4037-A670-AE7FC5F1652BQ34221539-148B02B4-152E-48A6-AA58-70105E30CC05Q34245650-BB1C93AB-15CF-4681-B106-2610FAC63D78Q34349036-D5C37557-D86A-4FCC-B396-D74F0942AFC1Q34380399-75B97269-B21A-4BCB-8D37-256AE19E4A41Q34439925-F427B4C7-EB0B-4BCF-92CF-F56095A971F7Q34474434-19BB0026-3757-4F19-96AD-15984561C7D3Q34505231-D19D80F3-DB96-48E1-B8DA-85E4DBCB64C0Q34736194-F4C25988-28DA-4974-9DD6-2B751D43B820Q35056682-A1FE4E23-7BEB-4857-8545-110120708B3DQ35125231-32925C0D-C3E4-4ECF-B47B-9FD528C7F259Q35157605-35D5C2F8-49FE-43BF-B139-C8EB156D8ED2Q35628281-4DC09316-593D-43A4-82B3-BD9F8B0AE1A5Q35882845-41041C07-27AE-43EB-BD7D-4320042C5488Q36034450-22625265-9BC6-46B2-83F1-F1756D407A92Q36055483-AD507A04-14EA-4C99-AA24-8C5480991224Q36079851-38ABAE68-78BF-43D2-8EC1-FC2B50AAC835Q36083457-39899DD7-0A3D-41E3-AB4C-8FED60FE9005Q36376632-068E78E6-64E7-47CB-AA3A-84F7F0AE68E8Q36479368-2C8951DC-AADC-4A37-9769-599B5AFA6410Q36521414-367B8936-7411-48E7-9015-33F356F4CF9BQ36555228-12E3E623-92DC-420D-B53C-A459BB26EC32Q36820091-7F91FAB7-4D3D-4824-862E-25EDCA701AB0Q37063803-AB4C8F70-9181-4584-9607-173BCF29F0BDQ37098184-0134414A-E0AA-40C2-9EDF-2ECDF3B7BC83Q37122490-B400FF61-CB50-41A4-8C64-AFA89131A769Q37235533-23F4CBF6-842E-4757-9490-4A6DBA03E547Q37481988-AABA5E48-44CB-48AB-BD17-7A6AB77012E8Q37579940-976197D6-9467-4477-A8BC-052C0BF50F40Q37607856-FFF0A368-7C9B-4699-A37F-EE87B590D1AAQ37663322-4D22F1D0-9C72-4290-A772-CCDDB4B55781
P2860
Impact of human immunodeficiency virus (HIV) infection on the progression of liver fibrosis in hepatitis C virus infected patients
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Impact of human immunodeficien ...... itis C virus infected patients
@ast
Impact of human immunodeficien ...... itis C virus infected patients
@en
type
label
Impact of human immunodeficien ...... itis C virus infected patients
@ast
Impact of human immunodeficien ...... itis C virus infected patients
@en
prefLabel
Impact of human immunodeficien ...... itis C virus infected patients
@ast
Impact of human immunodeficien ...... itis C virus infected patients
@en
P2093
P2860
P356
P1433
P1476
Impact of human immunodeficien ...... itis C virus infected patients
@en
P2093
A H Mohsen
B Portmann
P J Easterbrook
R Kulasegaram
P2860
P304
P356
10.1136/GUT.52.7.1035
P407
P577
2003-07-01T00:00:00Z